How choice of reactor vessel affects reaction performance
New report compares the thermal performance and advantages of vacuum jacketed versus non-vacuum jacketed reaction vessels.
Asynt has produced a new report that compares the thermal performance and advantages of vacuum jacketed versus non-vacuum jacketed reaction vessels.
Data is presented for vacuum jacketed and non-vacuum jacketed reaction vessels connected to a Julabo Presto A30 temperature control system. The report demonstrates that a vacuum jacketed vessel not only achieved faster rates of cooling but was also able to maintain a reaction at -20 °C compared with just -15 °C for the non-vacuum jacketed vessel. Using a vacuum jacketed vessel was also shown to eliminate ice formation on the outside of the reactor glass (a common problem with non-vacuum jacketed reaction vessels), allowing continuous viewing of the reactor contents.
By reducing heat loss/gain a glass vacuum jacket enables faster rates of heating and uses less energy to cool the system, thereby enabling lower temperatures to be achieved than reactor vessels without a vacuum jacket. The report concludes that using a vacuum jacketed reaction vessel will allow users to optimise thermal performance thereby improving control of reactions. In addition, the report proposes that the small additional cost of a vacuum jacketed vessel is easily justified not only by the additional performance but also by the cost saving of being able to use a lower powered temperature control system.
Vacuum jacketed reaction vessels are available as options for the Asynt ReactoMate Pilot (5-50 L) and for the Asynt ReactoMate Datum (100 mL - 5 L) reactor systems.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance